Physician Scientist, Cancer Biology – Providence, RI
Physician Scientist in Cancer Biology – Applicants with outstanding research accomplishments in basic cancer research and/or translational oncology.
Physician Scientist in Cancer Biology – Applicants with outstanding research accomplishments in basic cancer research and/or translational oncology.
Ruth Jessen Hickman, MD, is a freelance medical and science writer based in Bloomington, Indiana. Population: Roughly 1 in 200,000 people across ethnicities; may present…
Human epidermal growth factor receptor 2 (HER2) overexpression or amplification (ERBB2amp) are biomarkers for approved anti-HER2 therapies. ERBB2amp may better predict response compared with immunohistochemistry…
Before lung cancer resection, patients inquire about dyspnea and the potential need for supplemental oxygen. The objective of this study was to identify predictors of…
We explore the ongoing debate around NICE’s cost-effectiveness thresholds and what the future holds. Cost-effectiveness thresholds play a vital role in healthcare decision-making, helping to…
Nature – Large extrachromosomal DNAs are engineered using a CRISPR- and Cre–loxP-based approach and shown to drive cancer in mouse models, with potential applications in…
The U.S. has confirmed its first known severe human infection of H5N1 bird flu, in a person in Louisiana.
As the number of recipients of chimeric antigen receptor (CAR) T-cell therapies has rapidly increased, sporadic reports of T-cell lymphomas arising de novo
Oncogene – Tissue factor promotes TREX1 protein stability to evade cGAS-STING innate immune response in pancreatic ductal adenocarcinoma
Nature – A spatially resolved single-cell transcriptomics map of the mouse brain at different ages reveals signatures of ageing, rejuvenation and disease, including ageing effects…
Molecular Psychiatry – Monoallelic loss-of-function variants in GSK3B lead to autism and developmental delay